QA: Trisalus Life Sciences Inc in us_health_services/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001826667_2024_Trisalus_Life_Sciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001826667, Trisalus Life Sciences Inc

  xvar xval
0 IntangibleAssets 0
1 AssetsNonCurrent 1,645,000
2 AssetsCurrent 20,862,000
3 PropertyPlantAndEquipment 2,091,000
4 remainder_Assets 1,127,000
5 LongTermLiabilities 0
6 LiabilitiesCurrent 14,687,000
7 remainder_Liabilities 36,976,000
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 2,605,000
10 GeneralAndAdministrativeExpense 23,512,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 17,034,000
15 ResearchAndDevelopmentExpense 29,510,000
16 remainder_Expenses -10,268,000
17 remainder_Revenues 18,511,000
18 remainder_NetIncome -15,156,000
19 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 25,725,000
1 Liabilities 51,663,000
2 Expenses 62,393,000
3 Revenues 18,511,000
4 StockholdersEquity -25,938,000
5 NetIncome -59,038,000
6 ComprehensiveNetIncome -59,038,000
7 BaseVar 86,724,000
8 EconomicCapitalRatio -3.39

Edgar->Model Mapping

Feature Distribution